Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Spray Calcitonin for Aggressive Central Giant Cell Granuloma
NCT02358304Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2007
- Primary completion
- Feb 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TBRIA in central giant cell granuloma (CGCG), sponsored by Shiraz University of Medical Sciences. Started Sep 2007; status: completed.
02
Drugs
TBRIA
03
Conditions
central giant cell granuloma (CGCG)
Beyond the preview
Go deeper on NCT02358304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02358304.